Enthera Pharmaceuticals ("Enthera"), a clinical-stage biotech company developing a first-in-class antibody therapeutic targeting the Insulin Growth Factor Binding Protein 3 (IGFBP3)/TMEM219 pathway ...

Discover How Arialief Alleviates Nerve Pain, Supports Metabolic Health, and Enhances Mobility-Without the Side Effects of ...

Researchers are getting better at growing miniature organs and embryos in test tubes or on chips. This creates new ...

This study identifies 53BP1 as an interaction partner of GMCL1 (a likely CUL3 substrate receptor). The study seeks to link this finding to regulation of the mitotic surveillance pathway and paclitaxel ...

they found the former secreted more insulin when exposed to high levels of glucose. "Immature beta cells don't respond well to glucose. This told us that the vascularized model contained more ...

Wenzhou Medical University researchers have reimagined the spleen as a viable site for islet transplantation, enabling ...

The new model, called BaseFold, enables more reliable 3D structure predictions for larger and more complex proteins and, according to the company, is “poised to greatly accelerate AI-based drug ...

Researchers led by Maike Sander, Scientific Director of the Max Delbrück Center, have developed a vascularized organoid model of hormone secreting cells in the pancreas. The advance, published in ...

Abstract: Protein structure prediction (PSP ... In addition, using a self-attention mechanism allows the model to focus on the most important features for improving performance. We used the SPOT-1D ...

However, the improvement in these methods’ accuracy is frequently achieved at the cost of more intricate model architectures ... We propose the fuss-free structure, a simple and efficient architecture ...